| Cat. No. |
Product Name |
Information |
| PC-72532 |
YQ-0629
HIF-2α inhibitor
|
YQ-0629 is a specific HIF-2α inhibitor, binds to HIF-2α PAS-B domain with Kd of 57.5 uM. |
| PC-72330 |
HIF inhibitor 208
HIF inhibitor
|
HIF inhibitor 208 is a small molecule inhibitor of HIF pathway with IC50 of 0.5 nM. |
| PC-72329 |
Arylsulfonamide 64B
HIF inhibitor
|
Arylsulfonamide 64B (HIF inhibitor 64B) is a small molecule inhibitor of HIF pathway, blocks hypoxia-induced expression of c-Met and CXCR4 and uveal melanoma (UM) cell migration. |
| PC-38083 |
Izilendustat
HIF-PHD inhibitor
|
Izilendustat is a potent inhibitor of HIF prolyl hydroxylase (PHD) which stabilizes hypoxia inducible factor- 1 alpha (HIF- lα), as well as hypoxia inducible factor-2 (HIF-2).. |
| PC-38033 |
HIF-2α-IN-2
HIF-2α inhibitor
|
HIF-2α-IN-2 is a hypoxia-inducible factor (HIF-2α) inhibitor with IC50 of 16 nM in scintillation proximity assay, extracted from patent WO2015035223A1, Compound 232. |
| PC-35912 |
KCN1
HIF-1 inhibitor
|
KCN1 (HIF inhibitor KCN1) is a small molecule inhibitor of the HIF-1 pathway, antagonizes HIF transcription in bioassay, blocks the p300/HIF-1α interaction, and exert potent anticancer activity in vitro and in vivo. |
| PC-43531 |
Roxadustat
HIF-PHD inhibitor
|
Roxadustat (FG4592, FG-4592) is a potent, orally available HIF prolyl hydroxylase (HIF-PHD) with IC50 of 591.4 nM. |
| PC-44597 |
FG-2216
HIF-PHD inhibitor
|
FG-2216 (YM-311, IOX3) is a potent, selective small molecule inhibitor of HIF prolyl hydroxylase (HIF-PHD) with IC50 of 3.9 nM (PHD2). |
| PC-35269 |
IOX4
PHD2 inhibitor
|
IOX4 (PHD2 inhibitor IOX4) is a potent, selective inhibitor of prolyl hydroxylase domain enzyme PHD2 with IC50 of 1.6 nM, displays >1,000-fold selectivity for PHD2 over other 2OG-dependent dioxygenases. |
| PC-63449 |
TP0463518
HIF-PHD inhibitor
|
TP0463518 is a highly potent HIF prolyl hydroxylase (PHD) inhibitor with IC50 of 13 nM and 18 nM for human and rat PHD2, respectively. |
| PC-43267 |
PT2385
HIF-2α inhibitor
|
PT2385 (PT-2385) is a potent, selective, and orally active antagonist of HIF2α, binds to HIF2α PAS-B domain (Kd=50 nM) and disrupts HIF2α/ARNT dimer formation. |
| PC-43241 |
JNJ-42041935
HIF-PHD inhibitor
|
JNJ-42041935 is a potent, selective, 2-OG-competitive, reversible inhibitor of HIF-PHD with pKi of 7.91, 7.29 and 7.65 for PHD1, PHD2 and PHD3, respectively. |
